| 发明名称 |
IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER |
| 摘要 |
The invention described herein relates to therapeutic dosing regimens and combinations thereof for use in enhancing the therapeutic efficacy of anti-CS1 antibodies in combination with one or more immunotherapeutic agents. |
| 申请公布号 |
WO2017003990(A1) |
申请公布日期 |
2017.01.05 |
| 申请号 |
WO2016US39723 |
申请日期 |
2016.06.28 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
MULLIGAN, Christopher Lee;BARTLETT, Justin Blake;ROBBINS, Michael Darron |
| 分类号 |
A61P35/02;A61K31/454;A61K31/573;A61K39/395 |
主分类号 |
A61P35/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
